Alperovich, A., & Younes, A. (2016). Targeting CD30 Using Brentuximab Vedotin in the Treatment of Hodgkin Lymphoma. Cancer J.
Chicago Style CitationAlperovich, Anna, and Anas Younes. "Targeting CD30 Using Brentuximab Vedotin in the Treatment of Hodgkin Lymphoma." Cancer J 2016.
MLA CitationAlperovich, Anna, and Anas Younes. "Targeting CD30 Using Brentuximab Vedotin in the Treatment of Hodgkin Lymphoma." Cancer J 2016.
Warning: These citations may not always be 100% accurate.